Recently, several lines of evidence suggest that colorectal cancer containing a BRAF p.V600E mutation possesses more malignant potential when compared with other genotypes of colorectal cancer, including the KRAS/BRAF-wild-type tumor and the KRAS-mutated tumor. Here, KRAS is linked to neoplasm.